APA (7th ed.) Citation

Mansouri, N., Mirbahari, S. G., Zandian, R., & Farshchian, N. (2025). Survival Benefits of Palbociclib Plus Endocrine Therapy in HR+/HER2- Advanced Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Trials. Journal of Reports in Pharmaceutical Sciences, 13(1), 1. https://doi.org/10.5812/jrps-168222

Chicago Style (17th ed.) Citation

Mansouri, Nasrin, Seyed Ghasem Mirbahari, Roya Zandian, and Negin Farshchian. "Survival Benefits of Palbociclib Plus Endocrine Therapy in HR+/HER2- Advanced Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Trials." Journal of Reports in Pharmaceutical Sciences 13, no. 1 (2025): 1. https://doi.org/10.5812/jrps-168222.

MLA (9th ed.) Citation

Mansouri, Nasrin, et al. "Survival Benefits of Palbociclib Plus Endocrine Therapy in HR+/HER2- Advanced Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Trials." Journal of Reports in Pharmaceutical Sciences, vol. 13, no. 1, 2025, p. 1, https://doi.org/10.5812/jrps-168222.